Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections
2005
Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
52
References
88
Citations
NaN
KQI